到 2023 年，亚太地区的药用糖果市场预计将达到 27.57 亿美元，在预测期内实现了最快的复合年增长率。2017年亚太地区的药用糖果销售额已超过 1.01 亿公斤。亚太地区的药用糖果市场从 2013 年的 9260 万公斤增长到 2018 年的 1.045 亿公斤，销量复合年增长率为 2.5%。
市场范围包括含有草药和/或植物提取物的糖果、止咳药水、锭剂和所有其他声称健康的糖果产品，例如 Halls。亚太地区是最重要的市场，2017 年的市场份额为 34%，主要由印度和中国推动。在预测期内，中国是增长最快的药用糖果市场，其价值复合年增长率为 5.2%。扩大零售分销，如超市/大卖场，仍然是该地区的主要驱动力。
消费者对糖果产品的日益关注的健康问题增加了对产品中草药和活性成分的需求。含有抗酸剂、维生素和草药提取物等活性成分的药用糖果可用于预防此类情况，从而推动销售。草本植物，如瓜拉那、人参赋予能量，而提取物，如绿茶、超级水果提供抗氧化剂，增强免疫力。由于其在草药糖果市场的健康益处，对抗氧化剂的需求正在增长. 针叶樱桃和人参是该产品中消耗最多的活性成分，其次是绿茶提取物。越来越多地采用西方生活方式正在这些国家引起过敏性鼻炎。与发达国家相比，发展中地区的花粉热、哮喘和过敏原病例更为突出。由于天然和有机的性质及其健康要求，草本糖果越来越受欢迎。注入草药的药用糖果继续以更快的速度增长。然而，由于价格低廉和批量需求，预计未来维生素强化糖果的销售也将占主导地位。
中国主导着亚太地区的药用糖果市场，其次是日本。2017年亚太药用糖果市场规模约1.01亿公斤，增长速度较快。不断提高的生活水平和意识正在推动消费者转向更好的糖果产品。对价格敏感的小包装糖果的平均消费者支出增加，进一步支持了市场增长。尽管中国消费品经济放缓，但药用糖果表现良好。由于其健康益处，对草药注入产品的需求增加正在推动市场。由于感冒和咳嗽的影响增加，药用糖果的需求量很大，主要是在冬季。
亚太药用糖果市场竞争激烈，大量国内外企业争夺市场份额。宣称无糖的收购和产品创新是玩家采用的主要策略。
主要参与者包括雀巢公司、亿滋国际公司、宝洁公司、Perfetti Van Melle、Reckitt Benckiser Group plc、Ricola Ltd.等。
1. Introduction
1.1 Key Deliverables of the Study
1.2 Study Assumptions
1.3 Scope of the Market
2. Research Approach and Methodology
2.1 Introduction
2.2 Research Design
2.3 Study Timelines
2.4 Study Phases
2.4.1 Secondary Research
2.4.2 Discussion Guide
2.4.3 Market Engineering and Econometric Modeling
2.4.4 Expert Validation
3. Market Overview
3.1 Market Trends
3.2 Market Dynamics
3.2.1 Drivers
3.2.1.1 Consumers Seeking Relief from Hay-fever and Other Cold-related Issues
3.2.1.2 Ban on Smoking in Public Places and Reduced Number of Smokers in Japan
3.2.2 Restraints
3.2.2.1 Consumer Demands for Mint
3.2.3 Opportunities
3.2.3.1 Growing Consumer Demand for Active Ingredients In Confectionery
3.2.4 Porter's Five Forces Analysis
3.2.4.1 Bargaining Power of Suppliers
3.2.4.2 Bargaining Power of Buyers
3.2.4.3 Threat of New Entrants
3.2.4.4 Threat of Substitute Products and Services
3.2.4.5 Degree of Competition
4. Market Segmentation
4.1 By Distribution Channel
4.1.1 Convenience Stores
4.1.2 Specialist Retailers
4.1.3 Supermarkets and Hypermarkets
4.1.4 Online Retail
4.1.5 Variety Stores
4.1.6 Department Stores
4.1.7 Pharmacies
4.1.8 Others
4.2 By Geography
4.2.1 Asia-Pacific
4.2.1.1 China
4.2.1.2 India
4.2.1.3 Japan
4.2.1.4 Australia
4.2.1.5 Rest of Asia-Pacific
5. Competitive Landscape
5.1 Market Share Analysis
5.2 Strategy Adopted by Key Players
5.3 Most Active Companies in the Past Five Years
6. List of Company Profiles
6.1 Overview
6.2 Products & Services
6.3 Financials
6.4 Key Developments
6.5 Strategies Adopted
6.6 SWOT Analysis of Major Five Players
7. Companies Covered
7.1 Mondelēz International, Inc.
7.2 Nestlé SA
7.3 Procter & Gamble Co.
7.4 Perfetti Van Melle
7.5 Reckitt Benckiser Group Plc
7.6 Ricola Ltd
7.7 Wm. Wrigley Jr. Company
7.8 Herbion International Inc.
7.9 The Hershey Company
7.10 Mars, Incorporated
8. Appendix
8.1 Disclaimer
8.2 Sources
LIST OF TABLES
1: Medicated Confectionery Market: Revenue in USD million, by Country, Asia-Pacific, 2015-2023
2: Medicated Confectionery Market: Revenue in USD million, by Distribution Channel, Asia-Pacific, 2015-2023
3: Medicated Confectionery Market: Revenue in USD million, by Distribution Channel, India, 2015-2023
4: Medicated Confectionery Market: Revenue in USD million, by Distribution Channel, China, 2015-2023
5: Medicated Confectionery Market: Revenue in USD million, by Distribution Channel, Australia, 2015-2023
6: Medicated Confectionery Market: Revenue in USD million, by Distribution Channel, Japan, 2015-2023
7: Medicated Confectionery Market: Revenue in USD million, by Distribution Channel, Rest of Asia-Pacific, 2015-2023
8: Medicated Confectionery Market: Revenue in USD million, by Distribution Channel, Asia-Pacific, 2015-2023
9: Medicated Confectionery Market: Volume in million Kg, by Country, Asia-Pacific, 2015-2023
